Published in:
01-03-2011 | Letter to the Editor
Reply to: IL-2 and IFN-gamma and diabetic retinopathy
Authors:
Siv Johnsen-Soriano, María Sancho-Tello, Emma Arnal, Amparo Navea, Enrique Cervera, Francisco Bosch-Morell, Maria Miranda, Francisco Javier Romero
Published in:
Graefe's Archive for Clinical and Experimental Ophthalmology
|
Issue 3/2011
Login to get access
Excerpt
It is well-known that retinal changes in diabetes are thought to be initiated by sustained hyperglycemia and fluctuation of blood glucose, as suggested by Dr Viroj Wiwanitkit, leading to biochemical abnormalities, that include all alterations of various vasoactive and growth factors [
1], nonenzymatic glycation [
2,
3], increase in the polyol pathway and redox imbalance [
1,
4‐
9], and activation of protein kinase C (PKC) [
10,
11]. …